• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 19, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

AI better than most human experts at detecting cause of preemie blindness

Bioengineer by Bioengineer
May 3, 2018
in Health
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Michael Chiang/OHSU

PORTLAND, Oregon/BOSTON, Massachusetts – An algorithm that uses artificial intelligence can automatically and more accurately diagnose a potentially devastating cause of childhood blindness than most expert physicians, a paper published in JAMA Ophthalmology suggests.

The finding could help prevent blindness in more babies with the disease, called retinopathy of prematurity, or ROP. Musician Stevie Wonder went blind due to this condition.

The algorithm accurately diagnosed the condition in images of infant eyes 91 percent of the time. On the other hand, a team of eight physicians with ROP expertise who examined the same images had an average accuracy rate of 82 percent.

"There's a huge shortage of ophthalmologists who are trained and willing to diagnose ROP. This creates enormous gaps in care, even in the United States, and sadly leads too many children around the world to go undiagnosed," said the study's co-lead researcher, Michael Chiang, M.D., a professor of ophthalmology and medical informatics & clinical epidemiology in the OHSU School of Medicine and a pediatric ophthalmologist at the Elks Children's Eye Clinic in the OHSU Casey Eye Institute.

"This algorithm distills the knowledge of ophthalmologists who are skilled at identifying ROP and puts it into a mathematical model so clinicians who may not have that same wealth of experience can still help babies receive a timely, accurate diagnosis," said the other lead researcher, Jayashree Kalpathy-Cramer, Ph.D., of the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, who is also an associate professor of radiology at Harvard Medical School.

Leading cause of childhood blindness

Retinopathy of prematurity is caused by abnormal blood vessel growth near the retina, the light-sensitive portion in the back of an eye. The condition is common in premature babies and is the leading cause of childhood blindness globally.

The National Eye Institute of the National Institutes of Health reports that up to 16,000 U.S. babies experience retinopathy of prematurity to some degree, but only up to 600 become legally blind each year as a result. The condition is becoming more common as medical care for premature babies improves.

The disease is diagnosed by visually inspecting a baby's eye. Physicians typically use a magnifying device that shines light into a baby's dilated eye, but that approach can lead to variable and subjective diagnoses.

Computational smarts

Artificial intelligence, also called AI, enables machines to think like humans and is a growing field in health care. Last month, the FDA approved an AI device that detects diabetes-related eye disease. Others have tried developing computerized systems to diagnose retinopathy of prematurity, but none have been able to match the accuracy of visual diagnosis by physicians.

This algorithm specifically uses deep learning, a form of AI that mimics how humans perceive the world through vision, including identifying objects. The MGH researchers combined two existing AI models to create the algorithm, while the OHSU researchers developed extensive reference standards to train it.

They first trained the algorithm to identify retinal vessels in more than 5,000 pictures taken during infant visits to an ophthalmologist. Next, they trained it to differentiate between healthy and diseased vessels. Afterward, they compared the algorithm's accuracy with that of trained experts who viewed the same images and discovered it performed better than most of the expert physicians.

The full research team is now working with a collaborator in India to see if the algorithm can diagnose ROP in Indian babies as well as it did for the group of primarily Caucasian babies involved in this study. They are also exploring whether the algorithm can diagnose the condition in images of other parts of the retina besides vessels. The ultimate goal is to enable physicians to incorporate the technology into their clinical practices.

###

The paper's co-lead authors are James Brown, Ph.D., a research fellow at MGH and Harvard Medical School, and J. Peter Campbell, M.D., M.P.H., an assistant professor at the OHSU School of Medicine.

The paper was published on the same day as talks about the algorithm at ARVO 2018, the annual meeting of the Association for Research in Vision and Ophthalmology.

The institutions involved in this study were OHSU, Massachusetts General Hospital, University of Illinois at Chicago, Northeastern University, University of Miami, Columbia University Medical Center, William Beaumont Hospital, Children's Hospital Los Angeles, Cedars-Sinai Medical Center, LA Biomed at Harbor-UCLA Medical Center, and Asociación para Evitar la Ceguera en México.

This research was supported by the National Institutes of Health (grants R01EY019474, P30EY10572, P41EB015896 & T90DA022759/R90DA023427), the National Science Foundation (grants SCH1622542, SCH1622536, SCH1622679), Research to Prevent Blindness, and the Oregon State Elks.

PAPER: James M. Brown, J. Peter Campbell, Andrew Beers, Ken Chang, Susan Ostmo, R.V. Paul Chan, Jennifer Dy, Deniz Erdogmus, Statis Ioannidis, Jayashree Kalpathy-Cramer, Michael F. Chiang, "Automated diagnosis of plus disease in retinopathy of prematurity using deep convolutional neural networks," JAMA Ophthalmology, May 2, 2018, DOI: 10.1001/jamaophthalmol.2018.1934, https://media.jamanetwork.com/news-item/can-an-algorithm-detect-signs-of-a-serious-eye-disease-in-premature-infants-like-human-experts/.

ARVO 2018 talks:

  • J. Peter Campbell, "Artificial intelligence in retinopathy of prematurity: clinical validation of a fully automated deep learning system (i-ROP DL) for plus disease diagnosis," Presentation No. 3936, 8:45 a.m. Hawaii time, May 2, 2018.
  • Stanford Taylor, "Automated Computer-Based Image Analysis in Monitoring Disease Progression for Retinopathy of Prematurity, Presentation No. 3937, 9 a.m. Hawaii time, May 2, 2018
  • James Brown, "Artificial intelligence in retinopathy of prematurity: development of a fully automated deep convolutional neural network (DeepROP) for plus disease diagnosis," Presentation No. 3938, 9:15 a.m. Hawaii time, May 2, 2018

More info:

  • NIH website on retinopathy of prematurity: https://nei.nih.gov/health/rop/rop
  • Michael Chiang, M.D.: http://www.ohsu.edu/xd/health/services/casey-eye/research/research-faculty/chiang-lab.cfm
  • OHSU Casey Eye Institute: http://www.ohsu.edu/xd/health/services/casey-eye/
  • Jayashree Kalpathy-Cramer, Ph.D.: https://www.nmr.mgh.harvard.edu/user/8165
  • Massachusetts General Hospital's Athinoula A. Martinos Center for Biomedical Imaging: https://www.nmr.mgh.harvard.edu

Related:

  • 4/6/18 OHSU news story, "Telemedicine provides accurate diagnosis of rare cause of blindness in preemies," https://news.ohsu.edu/2018/04/06/telemedicine-provides-accurate-diagnosis-of-rare-cause-of-blindness-in-preemies

Media Contact

Franny White
[email protected]
971-413-1992
@ohsunews

http://www.ohsu.edu

Related Journal Article

http://dx.doi.org/10.1001/jamaophthalmol.2018.1934

Share12Tweet7Share2ShareShareShare1

Related Posts

Tirzepatide Enhances Blood Sugar Regulation in Adolescents with Type 2 Diabetes Unresponsive to Current Treatments (SURPASS-PEDS Trial)

September 18, 2025

Texas A&M Researchers Develop Innovative Cryopreservation Technique to Stop Organ Cracking

September 18, 2025

Optimizing Geriatric Care: Staff Insights on Patient Mobilization

September 18, 2025

Researchers Pinpoint Potential Therapeutic Targets in Pediatric Germ Cell Tumors

September 18, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    67 shares
    Share 27 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tirzepatide Enhances Blood Sugar Regulation in Adolescents with Type 2 Diabetes Unresponsive to Current Treatments (SURPASS-PEDS Trial)

Emerging Research Links Microplastics to Potential Risks for Bone Health

Early Universe Galaxies Unveil Hidden Dark Matter Maps

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.